Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations>
  4. Page 16

Betalin’s Micro-Pancreas to ‘Cure’ Diabetes Ready for UK Trials

August 15, 2020

Jerusalem based Betalin Therapeutics will be submitting a request to Britain’s regulatory agency in August for human clinical trials in the UK, for their Endocrine

Read More »

NOBIO COVID-19 Personal Protection Coatings Awarded Israel Innovation Authority Grant

August 5, 2020

Nobio  was recently awarded a $205,000 grant from the Israel Innovation Authority to rapidly develop personal protection and surface coatings with long acting, universal protection

Read More »

Yissum Spinouts Raise Record $79 million in H1 2020 Despite Coronavirus

August 5, 2020

(July 28, 2020– Jerusalem) Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020, Yissum, the technology transfer company

Read More »

New Israeli Trial on Possible Pomegranate Oil Prevents Age Related Brain Decline

August 5, 2020

Jerusalem based Granalix is to be teaming up with the Rambam Medical Center’s Memory Clinic on a new clinical trial to test the impact of

Read More »

Oramed Oral Insulin for Treatment of Diabetes Gets 3rd Phase Clinical Trials Greenlight

August 5, 2020

The Need Diabetes and its prevalence in modern society have been a major international health concern for some time. Health officials worldwide have seen the

Read More »
Anchiano-Therapeutics

Anchiano Appoints Stan Polovets as Chairman of the Board

July 18, 2020

Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”) recently announced that Mr. Stan Polovets has been elected chairman of its board of directors. Mr. Polovets joined the

Read More »
Gamida-Cell

Gamida Cell Adds David Fox to Board of Directors

July 18, 2020

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced that David

Read More »
Nectin-Therapeutics

JLM Immuno-Oncology Company Nectin raises $6m from Amoon

July 18, 2020

Nectin Therapeutics is developing a number of antibodies that can enhance the treatments being offered to cancer patients. Jerusalem immuno-oncology biotherapies company Nectin Therapeutics has

Read More »
Atox-Bio

Atox Bio’s Reltecimod Effective in Phase 3 Clinical Trials against Flesh Eating Disease

July 18, 2020

Reltecimod is Atox Bio‘s lead product in development and is currently in late stage clinical trials for Necrotizing Soft Tissue Infections (NSTI) (Flesh Eating Disease)

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Next »

JLM-BioCity Upcoming Events

JLM-BioCity-&-Columbia-Mission-2022a
To RSVP, contact Sara Gdanski, JLM-BioCity Corporate Relations Manager at 058-7922882
or email her at: sara.gdanski1 AT gmail.com

More JLM BioCity events coming soon…

What people are saying…

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

Ian Solomon CTO, OmnySense Ltd

The JLM Biocity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

Dror Chevion Concenter BioPharma

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

JLM-BioCity member Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

JLM-BioCity member Aurélie Schwarzbach

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

JLM-BioCity member Jonathan Miller

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

JLM BioCity Member Yael Ophir

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

JLM-BioCity Member Tal Or

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev
Next >>

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved